Global Human Vaccine Market 2018-2022 | 8% CAGR Projection over the Next Five Years | Technavio

Technavio has announced its latest market research report titled global human vaccine market 2018-2022. (Graphic: Business Wire)

LONDON--()--The global human vaccine market is expected to post a CAGR of close to 8% during the period 2018-2022, according to the latest market research report by Technavio.

A key factor driving the growth of the global human vaccine market size is the increase in investments in the vaccines segment. The development of a wide range of vaccines requires high investments to adhere to the aggressive timelines for vaccine development and life cycle management. Thus an increase in investments will fuel market growth during the forecast period.

As per Technavio, the varied demand for vaccines in high income and developing countries will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global human vaccine market 2018-2022 research report also analyzes other important trends and market drivers that will affect market growth over 2018-2022.

Global Human Vaccine Market: Varied Demand for Vaccines in High Income and Developing Regions

The need to develop novel vaccines to prevent various emerging and re-emerging infectious diseases is growing rapidly across the globe, especially in emerging countries. However, a varied demand for vaccines is seen across high, middle, and low-income countries. Middle-income countries receive lesser funding as compared to low-income countries from international agencies for immunization. Hence, they tend to prioritize traditional vaccines over novel vaccines. The demand for novel vaccines is high in developing countries, which receive financial support. Thus, the varied demand for vaccines will be a key trend in the market during the forecast period.

“Apart from the varied demand for vaccines in high-income and developing countries, other factors such as the increase in strategic alliances and M&A, will have a positive impact on the growth of the human vaccine market during the forecast period,” says a senior analyst at Technavio.

Global Human Vaccine Market: Segmentation Analysis

The global human vaccine market research report provides market segmentation by route of administration (oral, intramuscular, intradermal, subcutaneous, and intranasal) and by region (the Americas, EMEA, and APAC).

The Americas held the largest share of the market in 2017, followed by EMEA and APAC respectively. The dominance of the region can be due to the increasing prevalence of infectious diseases and a significant rise in the number of government initiatives.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Release Summary

The global human vaccine market is expected to post a CAGR of close to 8% during the period 2018-2022, according to Technavio.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200